Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 437028)

Published in J Clin Invest on December 01, 1983

Authors

D L Lucas, H K Webster, D G Wright

Articles cited by this

Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature (1977) 12.57

Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci U S A (1978) 9.59

Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet (1972) 9.01

Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med (1968) 6.91

Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature (1982) 6.78

Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci U S A (1980) 6.65

Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc Natl Acad Sci U S A (1982) 5.80

The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature (1980) 5.13

Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma viruses. Proc Natl Acad Sci U S A (1979) 4.34

Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Proc Natl Acad Sci U S A (1977) 2.90

Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med (1979) 2.80

Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation. J Cell Biol (1979) 2.28

Enzymology of cancer cells (second of two parts). N Engl J Med (1977) 2.00

Induction of erythroid differentiation in vitro by purines and purine analogues. Cell (1976) 1.76

IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature (1975) 1.62

Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by componuds which induce differentiation of murine leukemia cells. Int J Cancer (1980) 1.61

A role for adenosine deaminase in human monocyte maturation. J Clin Invest (1976) 1.55

Soluble factors required for eukaryotic protein synthesis. Annu Rev Biochem (1976) 1.42

Development of chemotactic responsiveness in myeloid precursor cells: studies with a human leukemia cell line. Proc Natl Acad Sci U S A (1980) 1.17

Induction of sporulation by inhibitory purines and related compounds. Biochim Biophys Acta (1978) 1.17

Abnormal regulation of methylthioadenosine and polyamine metabolism in methylthioadenosine phosphorylase-deficient human leukemic cell lines. Cancer Res (1980) 1.11

Metabolism and biochemistry of mycophenolic acid. Cancer Res (1972) 0.99

Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193). Biochem Pharmacol (1982) 0.98

Purine metabolism in murine virus-induced erythroleukemic cells during differentiation in vitro. Proc Natl Acad Sci U S A (1975) 0.96

2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases. J Med Chem (1982) 0.94

Synthesis of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid by a novel ring closure of imidazole precursors. J Am Chem Soc (1976) 0.94

Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemia. Biochim Biophys Acta (1968) 0.93

Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia. J Clin Invest (1978) 0.92

Mechanism of translocation. Binding equilibria between the ribosome, mRNA analogues, and cognate tRNAs. J Biol Chem (1982) 0.91

Application of simultaneous UV-radioactivity high-performance liquid chromatography to the study of intermediary metabolism. I. Purine nucleotides, nucleosides and bases. J Chromatogr (1981) 0.86

Actions of 3-deazaguanine and 3-deazaguanosine on variant lines of Chinese hamster ovary cells. Biochem Pharmacol (1981) 0.85

The in vitro inhibition of purine nucleotide biosynthesis by 2-beta-D-ribofuranosylthiazole-4-carboxamide. Biochem Biophys Res Commun (1981) 0.77

Inosine 5'-phosphate dehydrogenase activity in normal and leukemic blood cells. Klin Wochenschr (1979) 0.77

Articles by these authors

(truncated to the top 100)

The epidemiology of malaria in a Karen population on the western border of Thailand. Trans R Soc Trop Med Hyg (1996) 5.35

Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet (1993) 5.11

TREATMENT OF HEMORRHAGE AND TRAUMATIC SHOCK BY THE INTRAVENOUS USE OF LYOPHILE SERUM. Ann Surg (1938) 4.80

Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet (1991) 3.72

Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method. Am J Trop Med Hyg (1985) 3.54

Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg (1996) 3.36

Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis (1991) 2.87

Pontine and extrapontine myelinolysis. Brain (1979) 2.76

Role of secretory events in modulating human neutrophil chemotaxis. J Clin Invest (1978) 2.59

Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest (1981) 2.50

High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. J Infect Dis (1992) 2.21

Secretory responses of human neutrophils: exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo. J Immunol (1979) 2.20

Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis (1986) 2.18

Demonstration by the polymerase chain reaction of mixed Plasmodium falciparum and P. vivax infections undetected by conventional microscopy. Trans R Soc Trop Med Hyg (1993) 2.09

Detection of Plasmodium vivax by polymerase chain reaction in a field study. J Infect Dis (1993) 1.92

Increased gamma delta T cells in acute Plasmodium falciparum malaria. Immunol Lett (1990) 1.87

Malaria in splenectomized patients: report of four cases and review. Clin Infect Dis (1993) 1.85

The mobilization and extracellular release of granular enzymes from human leukocytes during phagocytosis. J Cell Biol (1972) 1.84

Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology (2008) 1.80

Detection of Plasmodium falciparum by polymerase chain reaction in a field study. J Infect Dis (1992) 1.77

Qualitative and semiquantitative polymerase chain reaction to predict Plasmodium falciparum treatment failure. J Infect Dis (1994) 1.61

The differential mobilization of human neutrophil granules. Effects of phorbol myristate acetate and ionophore A23187. Am J Pathol (1977) 1.60

Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis. Bone Marrow Transplant (2005) 1.55

Agranulocytosis associated with "Mexican aspirin" (dipyrone): evidence for an autoimmune mechanism affecting multipotential hematopoietic progenitors. Am J Hematol (1989) 1.53

Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood (1998) 1.48

A functional differentiation of human neutrophil granules: generation of C5a by a specific (secondary) granule product and inactivation of C5a by azurophil (primary) granule products. J Immunol (1977) 1.47

Megakaryocytes and megakaryocyte progenitors in human cord blood. Am J Pediatr Hematol Oncol (1992) 1.45

Human neutrophil elastase functions as a type III collagen "collagenase". Biochem Biophys Res Commun (1980) 1.43

Plasmodium falciparum pigment induces monocytes to release high levels of tumor necrosis factor-alpha and interleukin-1 beta. Am J Trop Med Hyg (1994) 1.43

Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood (1996) 1.42

Mobilized CD34+ cells selected as autografts in patients with primary light-chain amyloidosis: rationale and application. Transfusion (1998) 1.42

Lymphapheresis in rheumatoid arthritis. A randomized trial. Arthritis Rheum (1981) 1.41

Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood (2001) 1.35

Circumsporozoite genotyping of global isolates of Plasmodium vivax from dried blood specimens. J Clin Microbiol (1992) 1.33

Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in Thailand. Bull World Health Organ (1988) 1.29

Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J Infect Dis (1995) 1.26

Flow cytometric two-color staining technique for simultaneous determination of human erythrocyte membrane antigen and intracellular malarial DNA. Cytometry (1992) 1.25

Effects of levamisole on normal and abnormal leukocyte locomotion. J Clin Invest (1977) 1.23

Separation of the symphysis pubis in association with childbearing. A case report. J Bone Joint Surg Am (1988) 1.22

Type II mefloquine resistance in Thailand. Lancet (1982) 1.22

De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol (1989) 1.22

Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med (1981) 1.21

An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant (2001) 1.20

ELISA method for detecting Plasmodium falciparum circumsporozoite antibody. Bull World Health Organ (1989) 1.20

Human blood monocytes: characterization of negatively selected human monocytes and their suspension cell culture derivatives. Scand J Immunol (1981) 1.19

Development of immunity in natural Plasmodium falciparum malaria: antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32). J Clin Microbiol (1987) 1.18

Development of chemotactic responsiveness in myeloid precursor cells: studies with a human leukemia cell line. Proc Natl Acad Sci U S A (1980) 1.17

Polyclonal expansion of peripheral gamma delta T cells in human Plasmodium falciparum malaria. Infect Immun (1994) 1.16

Disorders of phagocyte chemotaxis. Ann Intern Med (1980) 1.15

Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine. Am J Trop Med Hyg (1992) 1.13

Quinine with tetracycline for the treatment of drug-resistant falciparum malaria in Thailand. Am J Trop Med Hyg (1992) 1.11

Cloning and characterization of mefloquine-resistant Plasmodium falciparum from Thailand. Am J Trop Med Hyg (1985) 1.11

Lymphocyte depletion by continuous flow cell centrifugation in rheumatoid arthritis: clinical effects. Arthritis Rheum (1979) 1.10

Human cyclic neutropenia: clinical review and long-term follow-up of patients. Medicine (Baltimore) (1981) 1.10

Immunology of human malaria. A cellular perspective. Parasite Immunol (1989) 1.07

Efficacy of intermittent colchicine therapy in familial Mediterranean fever. Ann Intern Med (1977) 1.07

Mobilization and extracellular release of granular enzymes from human leukocytes during phagocytosis: inhibition by colchicine and cortisol but not by salicylate. Arthritis Rheum (1974) 1.07

Acridine orange fluorescent microscopy and the detection of malaria in populations with low-density parasitemia. Am J Trop Med Hyg (1991) 1.07

Arteether: risks of two-week administration in Macaca mulatta. Am J Trop Med Hyg (1997) 1.06

Evaluation of WR250417 (a proguanil analog) for causal prophylactic activity in the Plasmodium cynomolgi-Macaca mulatta model. Am J Trop Med Hyg (1994) 1.06

Defective production of and response to IL-2 in acute human falciparum malaria. J Immunol (1988) 1.06

Response of Plasmodium vivax variants to chloroquine as determined by microscopy and quantitative polymerase chain reaction. Am J Trop Med Hyg (1993) 1.05

Cytoadherence characteristics of rosette-forming Plasmodium falciparum. Infect Immun (1992) 1.05

Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease. Ann Intern Med (2001) 1.04

Mobilization of sialidase from intracellular stores to the surface of human neutrophils and its role in stimulated adhesion responses of these cells. J Clin Invest (1991) 1.03

Assessing the delivery of neutrophils to tissues in neutropenia. Blood (1986) 1.03

Quantitation of Fansimef components (mefloquine + sulfadoxine + pyrimethamine) in human plasma by two high-performance liquid chromatographic methods. Ther Drug Monit (1991) 1.01

Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography. Am J Trop Med Hyg (1994) 1.01

Emergence of multidrug-resistant Plasmodium falciparum in Thailand: in vitro tracking. Am J Trop Med Hyg (1992) 1.00

Immune cell activation in melioidosis: increased serum levels of interferon-gamma and soluble interleukin-2 receptors without change in soluble CD8 protein. J Infect Dis (1991) 0.99

Alteration in cytoadherence and rosetting of Plasmodium falciparum-infected thalassemic red blood cells. Blood (1993) 0.98

Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis. Bone Marrow Transplant (2005) 0.98

Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis. Bone Marrow Transplant (2007) 0.97

Recurrent severe infections in a child with abnormal leukocyte function: possible relationship to increased microtubule assembly. Blood (1978) 0.97

Visceral leishmaniasis in the German shepherd dog. I. Infection, clinical disease, and clinical pathology. Vet Pathol (1984) 0.96

Human neutrophil degranulation. Methods Enzymol (1988) 0.96

ATP induces transient elevations of [Ca2+]i in human neutrophils and primes these cells for enhanced O2- generation. Lab Invest (1988) 0.96

Malaria chemoprophylaxis using proguanil/dapsone combinations on the Thai-Cambodian border. Am J Trop Med Hyg (1992) 0.95

Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplant (2006) 0.95

Adenosine deaminase in malaria infection: effect of 2'-deoxycoformycin in vivo. Adv Exp Med Biol (1984) 0.94

AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes. Am J Hematol (2006) 0.94

The presence of the HLA class II allele DPB1*0501 in ethnic Thais correlates with an enhanced vaccine-induced antibody response to a malaria sporozoite antigen. Eur J Immunol (1995) 0.94

Ciprofloxacin treatment of drug-resistant falciparum malaria. J Infect Dis (1991) 0.93

Chemical protection against single-strand breaks in DNA of gamma-irradiated E. coli. Radiat Res (1969) 0.93

Antimalarial properties of bredinin. Prediction based on identification of differences in human host-parasite purine metabolism. J Clin Invest (1982) 0.93

Functional changes in neutrophils collected by filtration leukapheresis and their relationship to cellular events that occur during adherence of neutrophils to nylon fibers. Exp Hematol (1979) 0.93

Lymphocyte depletion and immunosuppression with repeated leukapheresis by continuous flow centrifugation. Blood (1981) 0.92

Complete development of the liver stage of Plasmodium falciparum in a human hepatoma cell line. Am J Trop Med Hyg (1995) 0.92

Macrophage activation in falciparum malaria as measured by neopterin and interferon-gamma. Clin Exp Immunol (1990) 0.92

Circumsporozoite antibodies and falciparum malaria incidence in children living in a malaria endemic area. Bull World Health Organ (1988) 0.92

Survey of distribution of substance P, vasoactive intestinal polypeptide, cholecystokinin, neurotensin, Met-enkephalin, bombesin and PHI in the spinal cord of cat, dog, sloth and monkey. Peptides (1988) 0.91

Human malaria parasite adenosine deaminase. Characterization in host enzyme-deficient erythrocyte culture. J Biol Chem (1984) 0.91

Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria. Cytometry (1997) 0.90

A comparative field study of radiolabeled and enzyme-conjugated synthetic DNA probes for the diagnosis of falciparum malaria. Am J Trop Med Hyg (1988) 0.90

Prolonged elevations of soluble interleukin-2 receptors in tuberculosis. Am Rev Respir Dis (1989) 0.89

Functional abnormalities of human neutrophils collected by continuous flow filtration leukopheresis. Blood (1975) 0.89

In vitro sensitivity of Plasmodium falciparum isolates in Thailand to quinine and chloroquine, 1984-1990. Southeast Asian J Trop Med Public Health (1992) 0.89

Correction of human cyclic neutropenia with prednisolone. N Engl J Med (1978) 0.89

Naturally acquired circumsporozoite antibodies and their role in protection in endemic falciparum and vivax malaria. Am J Trop Med Hyg (1991) 0.88

Massive pelvis injuries treated with amputations: case reports and literature review. J Trauma (1997) 0.88